Our data illustrate that administration of the chemotherapeutic agent mitomycin in HCC cell lines results in a significant up-regulation of ASM activity (Figure 1), hence leading to a considerable accumulation of pro-apoptotic ceramide (Figure 2). The gene discussed is SMPD1; the disease is hepatocellular carcinoma.